361 Aufrufe 361 0 Kommentare 0 Kommentare

    BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO

    • HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility.
    • This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service Contract Research Organization. The move also supports HEALWELL's broader vision of building out clinical research capabilities and leveraging synergies across its business lines to drive growth and innovation in healthcare.
    • Biopharma will also be integrating with HEALWELL AI's leading edge data science and Artificial Intelligence platform to help advance research and development, disease detection and patient identification capabilities to support expedited patient trials.
    • Biopharma has completed over 2,200 clinical trials since inception with approximately 250 pharma clients, globally. This includes 4 of the top 25 largest pharmaceutical companies in the world.

    Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF)("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce its subsidiary, BioPharma Services Inc. ("BioPharma"), a leading Contract Research Organization ("CRO") specializing in early-phase clinical trials, is expanding into late stage patient trials through the integration of Canadian Phase Onward ("CPO"), a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility ("Polyclinic"). As the research arm of Polyclinic, CPO plays a pivotal role in facilitating patient enrolment and trial execution. This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service CRO. The move also supports HEALWELL's broader vision of building out clinical research capabilities and leveraging synergies across its business lines to drive growth and innovation in healthcare.

    Seite 1 von 5



    Diskutieren Sie über die enthaltenen Werte



    newsfile
    0 Follower
    Autor folgen

    Verfasst von newsfile
    BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty …